雷扎金对Candida auris的活性
Jeffrey B Locke1, David Andes2, Shawn Flanagan1
1Cidara Therapeutics, Inc., San Diego, CA, USA.
The Journal of antimicrobial chemotherapy
|April 30, 2025
概括
雷扎金对Candida auris具有有前途的抗真菌活性,Candida auris是一种导致侵入性感染的多药耐药病原体. 需要进一步的临床研究来证实其在治疗候群血症和侵袭性候群病的有效性.
科学领域:
- 传染性疾病 传染性疾病
- 菌类学 菌类学是指菌类学.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 阳光 Candida auris导致越来越普遍的,多药耐药的候群病和具有高死亡率的侵袭性候群病.
- 现有治疗方法受到耐药性的挑战,需要新的治疗选择.
研究的目的:
- 审查关于雷扎金抗 Candida auris 的活性和有效性的现有证据.
- 评估雷扎金作为对C. auris感染的潜在治疗方法.
主要方法:
- 在体外,体内非临床实验和药物动力学/药物动力学分析的文献综述.
- 评估雷扎金抗 Candida 菌种的功效和活性范围.
主要成果:
- 雷扎金在体外和体内表现出对C. auris的抗真菌活性,与其他 echinocandins相比或优于其.
- 对野生类型和一些耐药分离物的活性保持不变,但在fks-突变菌株中减少.
- 药理动力学数据表明有利的剂量和暴露特征.
结论:
- 雷扎金显示出潜在的潜力,作为一种可行的治疗选择,用于候选血症和由C. auris引起的侵入性候选症.
- 有限的临床数据需要进一步研究以确定治疗疗效.
相关概念视频
Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


